Establishing a Prognostic Risk Model with the Key Gene Based on WGCNA and LASSO Regression in Pancreatic Cancer

CHEN Yijing, DENG Wei, YANG Chunmei

PDF(4366 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(4366 KB)
Labeled Immunoassays and Clinical Medicine ›› 2025, Vol. 32 ›› Issue (3) : 592-598. DOI: 10.11748/bjmy.issn.1006-1703.2025.03.026
Basic Research

Establishing a Prognostic Risk Model with the Key Gene Based on WGCNA and LASSO Regression in Pancreatic Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 32(3): 592-598 https://doi.org/10.11748/bjmy.issn.1006-1703.2025.03.026

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4366 KB)

Accesses

Citation

Detail

Sections
Recommended

/